The Army has exhausted nearly all its fiscal 2026 munitions budget and is asking Congress for special spending authority to protect critical missile production under long-term contracts with Lockheed Martin. The request signals concern that a full-year continuing resolution could force reordering of weapons priorities and undermine production expansion plans dependent on $350 billion in proposed mandatory FY-27 funding.
What's happening
- The Army has obligated or expended nearly all FY-26 munitions funding, closing off reprogramming options for emerging requirements.
- The department requested an anomaly to any continuing resolution to provide special authority for prioritized munitions programs covered by the Munitions Acceleration Council.
- The Army targets definitization of its seven-year PAC-3 MSE contract with Lockheed Martin between late October and November, with total potential value of $58.6 billion.
- FY-27 budget depends on $12.5 billion in mandatory funding for 2,936 PAC-3 MSE interceptors and $10.5 billion for 830 THAAD interceptors, alongside discretionary funding.
Why it matters
- A full-year CR would force the Army to shift resources among weapons programs, potentially delaying lower-priority munitions acquisitions to preserve highest-priority investments.
- Production expansion under the seven-year contracts depends on credible government purchasing commitments to justify private capital investment in manufacturing capacity.
- The fractured FY-27 funding plan, split across discretionary appropriations, reconciliation-based mandatory spending and supplemental requests, creates uncertainty for production planning timelines.
Going deeper
- The PAC-3 MSE arrangement stems from a July 29 award of a seven-year undefinitized contract action modification valued at up to $53.9 billion, building on a $4.7 billion undefinitized action from April 9.
- The April 9 award was largely financed through foreign military sales, with $4.5 billion from international customers and $264 million in FY-26 Army missile procurement funds.
- The seven-year arrangement formalized a framework agreement announced in January intended to encourage manufacturers to finance capacity increases in exchange for long-term purchasing commitments.
Financial impact
- PAC-3 MSE contract definitization targets Q4 2026, with total potential value of $58.6 billion recognizable over the seven-year period of performance as deliveries occur.
- Production expansion depends on FY-27 mandatory funding passage through reconciliation; without it, discretionary-only funding would be $1.4 billion for 267 PAC-3 MSE interceptors versus $12.5 billion planned for 2,936 units.
- THAAD production similarly faces uncertainty, with FY-27 discretionary request of $1.9 billion for 27 interceptors against $10.5 billion mandatory funding proposal for 830 units.
The intrigue
- Congress has not yet enacted the reconciliation funding underpinning the missile procurement expansion, leaving the Army's production objectives exposed to decisions outside regular appropriations.
- The CR anomaly request outcome is uncertain; Lt. Gen. Lozano stated he does not know if Congress will grant the authority to protect the identified munitions programs.
The fine print
- The PAC-3 MSE contract remains undefinitized pending definitization completion between late October and November 2026; final terms and pricing to be confirmed.
- Neither the Army official identified which programs might lose funding or face delays under a full-year CR scenario.
- The department separately requested supplemental appropriations; whether Congress approves that request remains undetermined.


